OpenEvidence
AI employees & digital coworkersOpenEvidence
OpenEvidence is a medical search and chat tool for doctors. It answers clinical questions with citations from licensed journals, and it is free to verified clinicians.
- For physicians
- Free to verified clinicians
- Cited answers
- Content from NEJM and JAMA
At a glance
$15B valuationVerifiedAs of Sep 30, 2026Forbes
Evidence notes
- Evidence level: Verified, secondary.
- Valuation is the only scored figure. The CEO confirmed it to Forbes.
- A $250 million raise, confirmed by the CEO. The January 2026 round was valued at $12 billion (TechCrunch).
Key facts
As of Nov 11, 2026
- Who it's for
- Physicians and clinical teams who want cited answers to clinical questions.
- Who can use it?
- Verified clinicians. Access is free to doctors, confirmed by NPI or hospital email.
- What does it do?
- Medical search and chat for doctors: ask a clinical question and get an answer with citations drawn from licensed sources. OpenEvidence lists content agreements with NEJM, JAMA, Nature, NCCN and Cochrane, and added the American College of Physicians on Nov 9, 2026.
- How is it priced?
- Free for verified clinicians, supported by advertising.
- Health-system and content partners
- Health-system partnerships such as NYU Langone Health (announced Oct 29, 2026) and publisher content deals. A Learn platform for personalized medical education was announced Nov 4, 2026.
- How many clinicians use it?
- OpenEvidence says about 18 million clinical consultations in December 2025, and the New York Times reports 30 million questions in May 2026. All figures are company statements.
- Funding and valuation
- $250M raise at a $15B valuation, confirmed by the CEO to Forbes on Sep 30, 2026. Earlier: $12B in January 2026.
Sources
- ↗ www.fiercehealthcare.com/ai-and-machine-learning/openevidence-clinches-250m-series-d-rapidly-growing-its-reach-doctors
- ↗ sacra.com/c/openevidence/
- ↗ www.openevidence.com/announcements
- ↗ www.nytimes.com/2026/06/08/business/ai-medicine-doctors.html
- ↗ www.forbes.com/sites/saibala/2026/09/30/openevidence-confirms-it-has-raised-an-additional-250-million-at-a-15-billion-valuation/
Recently
- Nov 9, 2026Licensing deal with the American College of Physicians, including Annals of Internal Medicine content.
- Nov 6, 2026Collaboration with the American College of Rheumatology on patient education.
- Nov 4, 2026Announced Learn, a personalized medical education platform.
- Oct 29, 2026Partnership with NYU Langone Health covering 12 million visits.
Common questions
What is OpenEvidence?
OpenEvidence is a medical search and chat tool for doctors. It answers clinical questions with citations from licensed journals, and it is free to verified clinicians.
Who is OpenEvidence for?
Physicians and clinical teams who want cited answers to clinical questions.
How much does OpenEvidence cost?
Free for verified clinicians, supported by advertising. Checked against the vendor's pages on Nov 11, 2026. Plans change often, so confirm before you decide.
Does OpenEvidence run locally or in the cloud?
OpenEvidence runs in the vendor's cloud. You use it through chat apps and an API.
What are alternatives to OpenEvidence?
See the AI employees & digital coworkers shortlist for the other options.
Compare OpenEvidence
No head-to-head pages for this one yet.